Illumina's Jay Flatley tells the story of his 2011 meeting with Roche in a video from Biocom's Speaker Series posted by the San Diego Union-Tribune.

In 2011, Illumina's stock price fell from the $70-a-share to $60-a-share range to about $24 a share, and that, Flatley says, was the impetus for Roche to come calling.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.